Disease spectrum of myopathies with elevated aldolase and normal creatine kinase
1
Issued Date
2023-01-01
Resource Type
ISSN
13515101
eISSN
14681331
Scopus ID
2-s2.0-85175965443
Journal Title
European Journal of Neurology
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Journal of Neurology (2023)
Suggested Citation
Soontrapa P. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. European Journal of Neurology (2023). doi:10.1111/ene.16117 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/91051
Title
Disease spectrum of myopathies with elevated aldolase and normal creatine kinase
Author(s)
Other Contributor(s)
Abstract
Background and purpose: Elevation of serum creatine kinase (CK) or hyperCKemia is considered a biological marker of myopathies. However, selective elevation of serum aldolase with normal CK has been reported in a few myopathies, including dermatomyositis, immune-mediated myopathy with perimysial pathology and fasciitis with associated myopathy. The aim was to investigate the disease spectrum of myopathies with isolated aldolase elevation. Methods: Medical records were reviewed to identify patients >18 years old seen between December 1994 and June 2020 who had pathologically proven myopathies with elevated aldolase and normal CK level. Patients with alternative causes of aldolase elevation were excluded. Results: Thirty-four patients with various types of myopathies were identified. Myopathies were treatable in 27 patients. The three most common etiologies were dermatomyositis (n = 8), overlap myositis (n = 4) and nonspecific myopathy (n = 4). Perimysial pathology comprising inflammation, fragmentation, vasculitis, calcified perimysial vessels or extracellular amyloid deposition was found in 17/34 patients (50%). Eight dermatomyositis patients with selective elevated aldolase were compared to 24 sex- and age-matched patients with dermatomyositis and hyperCKemia. Dermatomyositis patients with normal CK significantly (p < 0.05) had less frequent cutaneous involvement (50.0% vs. 100.0%) and fibrillation potentials (50.0% vs. 90.5%) but higher median erythrocyte sedimentation rate (33.5 vs. 13.5 mm/h) and more common perifascicular mitochondrial pathology (37.5% vs. 4.2%). Conclusion: Isolated aldolase elevation can be found in a greater variety of myopathies than initially thought and most were treatable. Dermatomyositis is the most common myopathy with selective elevation of aldolase in our cohort, which features some unique characteristics compared to dermatomyositis with hyperCKemia.